Breaking News Instant updates and real-time market news.

ALGN

Align Technology

$297.12

1.14 (0.39%)

07:07
04/25/19
04/25
07:07
04/25/19
07:07

Align Technology price target raised to $355 from $335 at Barclays

Barclays analyst Steve Valiquette raised his price target for Align Technology to $355 from $335 saying the company's Q1 results checked the box in every key category. The "timing to invest in Align could not be much better, particularly for investors looking for healthcare franchises that are relatively shielded from Medicare for All risk," Valiquette tells investors in a post-earnings research note. He keeps an Overweight rating on the shares.

  • 15

    May

  • 05

    Jun

ALGN Align Technology
$297.12

1.14 (0.39%)

04/17/19
GUGG
04/17/19
INITIATION
Target $335
GUGG
Buy
Align Technology initiated with a Buy at Guggenheim
Guggenheim initiated Align Technology with a Buy and $335 price target.
04/17/19
GUGG
04/17/19
INITIATION
Target $335
GUGG
Buy
Align Technology initiated with a Buy at Guggenheim
Guggenheim analyst Glen Santangelo initiated Align Technology with a Buy rating and a price target of $335. The analyst says the stock price has started to recover recently following a 53% peak to trough pullback in Q4, as investors appear to have "digested the concerns around decelerating growth and pricing." With "no meaningful competition on the horizon", Santangelo is retaining his positive view on the "global penetration opportunity" for Align Technology, given the low global penetration for its clear aligners and iTero scanners as well as signs of traction in the company's international market sales efforts.
04/23/19
PIPR
04/23/19
NO CHANGE
PIPR
Piper sees Q1 revenue upside for Inogen, Teleflex, Align Technology
Piper Jaffray analyst Matt O'Brien says his deep dive into the MedTech companies exploring the direct-to-consumer sales channel came up "most compelling" for Inogen (INGN), Teleflex (TFX) and Align Technology (ALGN). Website traffic at these companies is at or near three-year highs and historical trends suggest a high likelihood of revenue upside in Q1, O'Brien tells investors in a research note. The analyst also found DexCom's (DXCM) website traffic to be at three-year highs.
04/25/19
PIPR
04/25/19
NO CHANGE
Target $350
PIPR
Overweight
Align Technology price target raised to $350 from $300 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Align Technology to $350 from $300 saying the company posted a Q1 top- and bottom-line beat and introduced above-Street Q2 revenue guidance. Sentiment on the shares should continue improving as the quarter demonstrated the company's momentum in key growth drivers of North America utilization, international, and teen along with "potentially stabilizing" pricing should set up Align for "multiple years of top-tier growth," O'Brien tells investors in a post-earnings research note. While the analyst gets the sense that the company will invest heavily again this year to support future growth, he believes margin pressure may not be as bad as he feared last quarter. O'Brien reiterates an Overweight rating on Align Technology.

TODAY'S FREE FLY STORIES

JD

JD.com

$28.91

-0.17 (-0.58%)

06:21
06/25/19
06/25
06:21
06/25/19
06:21
Periodicals
JD.com's logistics unit raises $218M investment fund, Reuters reports »

The logistics division of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$311.63

-15.05 (-4.61%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Downgrade
Shopify rating change  »

Shopify downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CBMG

Cellular Biomedicine

$15.01

(0.00%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Initiation
Cellular Biomedicine initiated  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$47.63

0.17 (0.36%)

06:18
06/25/19
06/25
06:18
06/25/19
06:18
Periodicals
Intel plans to cut desktop processor prices by up to 15%, DigiTimes reports »

Intel is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

06:15
06/25/19
06/25
06:15
06/25/19
06:15
Periodicals
U.S.: Turkey would lose F-35 if Russia arms deal moves forward, Reuters says »

The U.S. cannot allow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

06:12
06/25/19
06/25
06:12
06/25/19
06:12
Periodicals
Nissan overhauls board following disorderly investor meeting, WSJ reports »

Nissan investors voted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVTL

Pivotal Software

$11.35

-0.15 (-1.30%)

06:11
06/25/19
06/25
06:11
06/25/19
06:11
Downgrade
Pivotal Software rating change  »

Pivotal Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

, GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

06:08
06/25/19
06/25
06:08
06/25/19
06:08
Periodicals
Alphabet's Sidewalk Labs meets resistance over Toronto plans, WSJ reports »

Sidewalk Labs, a unit of…

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

LEN

Lennar

$51.41

0.09 (0.18%)

06:07
06/25/19
06/25
06:07
06/25/19
06:07
Earnings
Lennar reports Q2 EPS $1.30, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

BAS

Basic Energy

$2.43

-0.21 (-7.95%)

06:07
06/25/19
06/25
06:07
06/25/19
06:07
Downgrade
Basic Energy rating change  »

Basic Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

FTSI

FTS International

$5.77

-0.5 (-7.97%)

06:06
06/25/19
06/25
06:06
06/25/19
06:06
Downgrade
FTS International rating change  »

FTS International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$3.00

-0.09 (-2.91%)

06:05
06/25/19
06/25
06:05
06/25/19
06:05
Hot Stocks
Immuron Directors increase shareholdings in the company »

Immuron wishes to advise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USWS

U.S. Well Services

$5.18

-0.38 (-6.83%)

06:05
06/25/19
06/25
06:05
06/25/19
06:05
Hot Stocks
U.S. Well Services signs agreement with AmeriMex Motor & Controls »

U.S. Well Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMCR

Amcor

$11.14

0.12 (1.09%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Hot Stocks
Amcor enters into $394M agreement for sale of three flexible packaging plants »

Amcor announces it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$15.38

0.15 (0.98%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Hot Stocks
Rice Team urges EQT Corporation shareholders to vote for Rice Team nominees »

The Rice Team,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

PLL

Piedmont Lithium

$11.50

(0.00%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Hot Stocks
Piedmont Lithium announces 47% increase in Piedmont mineral resource estimate »

Piedmont Lithium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEN

Genesis Healthcare

$1.23

0.01 (0.82%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Periodicals
HUD-backed nursing homes have 'serious deficiencies,' NY Times reports »

Dozens of nursing homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

06:02
06/25/19
06/25
06:02
06/25/19
06:02
Initiation
Viking Therapeutics initiated  »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

CTRP

Ctrip

$36.43

0.37 (1.03%)

06:00
06/25/19
06/25
06:00
06/25/19
06:00
Hot Stocks
Ctrip enters strategic partnership with Tourism Fiji »

Ctrip has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$101.39

-3.73 (-3.55%)

, VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

05:58
06/25/19
06/25
05:58
06/25/19
05:58
Initiation
Madrigal Pharmaceuticals, Viking Therapeutics, Genfit initiated  »

Madrigal Pharmaceuticals…

MDGL

Madrigal Pharmaceuticals

$101.39

-3.73 (-3.55%)

VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

GNFT

Genfit

$20.19

-0.02 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

RGEN

Repligen

$81.92

-1.09 (-1.31%)

05:55
06/25/19
06/25
05:55
06/25/19
05:55
Conference/Events
Repligen management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

NRCG

NRC Group

$11.04

2.23 (25.31%)

, ECOL

US Ecology

$57.37

-5.38 (-8.57%)

05:54
06/25/19
06/25
05:54
06/25/19
05:54
Downgrade
NRC Group, US Ecology rating change  »

NRC Group downgraded to…

NRCG

NRC Group

$11.04

2.23 (25.31%)

ECOL

US Ecology

$57.37

-5.38 (-8.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XHR

Xenia Hotels

$20.41

-0.55 (-2.62%)

05:45
06/25/19
06/25
05:45
06/25/19
05:45
Initiation
Xenia Hotels initiated  »

Xenia Hotels initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCE

Arco Platform

$43.38

-2.35 (-5.14%)

05:41
06/25/19
06/25
05:41
06/25/19
05:41
Initiation
Arco Platform initiated  »

Arco Platform initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$129.65

-1.32 (-1.01%)

, EOLS

Evolus

$13.69

0.13 (0.96%)

05:40
06/25/19
06/25
05:40
06/25/19
05:40
Recommendations
Allergan, Evolus analyst commentary at Mizuho »

Allergan price target…

AGN

Allergan

$129.65

-1.32 (-1.01%)

EOLS

Evolus

$13.69

0.13 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.